09.03.2011 • NewsSouth AfricaSasolOPEC

Sasol Hedges 30% Of Synthetic Fuel, Crude Output

South African petrochemical group Sasol said it had hedged about 30% of its South African synthetic fuels and West African crude oil output against a fall in oil prices.

Sasol said in a statement on Tuesday the transaction was for 4.56 million barrels of oil. The company's spokeswoman said the execution of the hedge was completed on March 7.

Sasol said the hedge would give it downside protection should monthly average dated Brent crude oil prices fall below $85 per barrel. It expected to incur losses should the monthly average oil prices exceed a volume-weighted average of $172.77 per barrel.

"Call levels between $170 per barrel and $175 per barrel were entered into," Sasol said.

Oil prices fell on Tuesday as OPEC considered boosting production for the first time in more than two years, with Brent crude prices dropping 1.45% to $113.37 per barrel.

Sasol shares closed 0.88% lower at 385 rand, compared with a 1.6% fall in Johannesburg's Top-40 index of blue chips. Sasol also said Tuesday it would pay C$1.05 billion ($1.1 billion) for its second shale gas interest in Canada to boost its gas portfolio and secure feedstock for gas-to-liquids plants.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.